These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2906088)

  • 21. Association of negative symptoms with tardive dyskinesia in schizophrenic patients.
    Chiu H; Lau J; Lam L; Shum P
    Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness.
    Arango C; Adami H; Sherr JD; Thaker GK; Carpenter WT
    Am J Psychiatry; 1999 Jul; 156(7):1097-9. PubMed ID: 10401460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tardive dyskinesia induced by classical antipsychotic drugs: a Tunisian sample of schizophrenics].
    Sejil I; Oumaya A; Bouguerra C; Mehdi F; Bellaaj R; Gallali S
    Encephale; 2013 May; 39 Suppl 1():S36-41. PubMed ID: 23219594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of attention/information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenics.
    Spohn HE; Coyne L
    Brain Cogn; 1993 Sep; 23(1):28-39. PubMed ID: 8105820
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and risk factors for tardive dyskinesia: a study in an Italian population of chronic schizophrenics.
    Altamura AC; Cavallaro R; Regazzetti MG
    Eur Arch Psychiatry Clin Neurosci; 1990; 240(1):9-12. PubMed ID: 1979540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spatial working memory deficits in schizophrenia: relationship with tardive dyskinesia and negative symptoms.
    Pantelis C; Stuart GW; Nelson HE; Robbins TW; Barnes TR
    Am J Psychiatry; 2001 Aug; 158(8):1276-85. PubMed ID: 11481163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The significance of subtyping tardive dyskinesia: a study of prevalence and associated factors.
    Gureje O
    Psychol Med; 1989 Feb; 19(1):121-8. PubMed ID: 2567019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The present status of tardive dyskinesia and akathisia in the treatment of schizophrenia.
    Barnes TR
    Psychiatr Dev; 1987; 5(4):301-19. PubMed ID: 2895467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III.
    van Harten PN; Hoek HW; Matroos GE; Koeter M; Kahn RS
    Am J Psychiatry; 1998 Apr; 155(4):565-7. PubMed ID: 9546009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tardive dyskinesia and glucid metabolism.
    Brousse G; Meary A; Mouret J; Blanc O; Hueber T; Lemoine P; Llorca PM; Lachaux B
    Hum Psychopharmacol; 2007 Aug; 22(6):373-80. PubMed ID: 17579925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tardive dyskinesia.
    Casey DE
    West J Med; 1990 Nov; 153(5):535-41. PubMed ID: 1979705
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia.
    Rapaport MH; Lohr JB
    Acta Psychiatr Scand; 1994 Nov; 90(5):311-5. PubMed ID: 7872033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tardive dyskinesia in schizophrenia. Relationship to minor physical anomalies, frontal lobe dysfunction and cerebral structure on magnetic resonance imaging.
    Waddington JL; O'Callaghan E; Buckley P; Madigan C; Redmond O; Stack JP; Kinsella A; Larkin C; Ennis JT
    Br J Psychiatry; 1995 Jul; 167(1):41-4. PubMed ID: 7551606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive impairment, clinical course and treatment history in out-patients with bipolar affective disorder: relationship to tardive dyskinesia.
    Waddington JL; Brown K; O'Neill J; McKeon P; Kinsella A
    Psychol Med; 1989 Nov; 19(4):897-902. PubMed ID: 2574475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negative symptoms, cognitive dysfunction, tardive akathisia and tardive dyskinesia.
    Sachdev P; Hume F; Toohey P; Doutney C
    Acta Psychiatr Scand; 1996 Jun; 93(6):451-9. PubMed ID: 8831862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of neuroleptic dose and tardive dyskinesia to attention, information-processing, and psychophysiology in medicated schizophrenics.
    Spohn HE; Coyne L; Lacoursiere R; Mazur D; Hayes K
    Arch Gen Psychiatry; 1985 Sep; 42(9):849-59. PubMed ID: 2864028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Facial dyskinesia: a 16-year follow-up study.
    McClelland HA; Metcalfe AV; Kerr TA; Dutta D; Watson P
    Br J Psychiatry; 1991 May; 158():691-6. PubMed ID: 1677601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship of extrapyramidal symptoms to age at onset and drug treatment in middle-aged and elderly schizophrenic patients.
    Srinivasan TN; Thara R; Padmavathi R; McCreadie RG
    Schizophr Res; 2001 Jan; 47(1):69-75. PubMed ID: 11163546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE; Kuskowski MA; Caligiuri MP
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.